Title: The Innovations of Hang-Ching Lin
Introduction
Hang-Ching Lin is a notable inventor based in China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating amyloid beta peptide-associated diseases. His work reflects a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Hang-Ching Lin holds several innovative patents, including a pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions. This composition contains isoacteoside to acteoside, which is effective in inhibiting the formation, accumulation, or aggregation of amyloid beta peptides. The weight ratio of isoacteoside to acteoside is between 4:1 to 1:4. Another notable patent involves a method for providing poria cocos extract of K2 with an increment. This method includes several steps, such as mixing poria cocos with a solvent, alkalifying, acidizing, and neutralizing the mixture to achieve a pH value greater than 7.
Career Highlights
Hang-Ching Lin is associated with Sinphar Tian-li Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a focus on developing effective treatments for complex diseases.
Collaborations
He collaborates with esteemed colleagues, including Tsu-Chung Chang and Wen-Liang Chang, who contribute to his research and development efforts.
Conclusion
Hang-Ching Lin's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare solutions. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective treatments.